Displaying 281 - 300 of 1504
Federal Trade Commission and Justice Department Announce Expedited Antitrust Procedure and Guidance for Coronavirus Public Health Efforts
FTC Imposes Conditions on Danaher Corporation’s Acquisition of GE Biopharma
Thomas Jefferson University, et al.
The Federal Trade Commission has issued an administrative complaint and authorized a federal court action to block the proposed merger of Jefferson Health and Albert Einstein Healthcare Network, two leading providers of inpatient general acute care hospital services and inpatient acute rehabilitation services in both Philadelphia County and Montgomery County, Pennsylvania. The proposed merger would eliminate the robust competition between Jefferson and Einstein for inclusion in health insurance companies’ hospital networks to the detriment of patients. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 4-0-1, with Chairman Joseph J. Simons recused. The administrative trial is scheduled to begin on Sept. 1, 2020.
FTC Submits Comment on Final Information Blocking Rule to the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology
FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus
FDA / FTC Workshop on a Competitive Marketplace for Biosimilars
Marketers of Pain Relief Device Settle FTC False Advertising Complaint
FTC, FDA to Hold Workshop on Promoting Competition in Markets for Biologics
Grade A Nutraceuticals (CannaPure CBD Oil)
FTC and Commonwealth of Pennsylvania Challenge Proposed Merger of Two Major Philadelphia-area Hospital Systems
Zero Gravity Skin (Perfectio medical devices)
FTC Requires Veterinary Service Providers Compassion First and National Veterinary Associates to Divest Assets in Three Local Markets
FTC Acts to Stop Two Companies from Making Unproven Bone and Joint Claims
FTC, FDA Sign Joint Statement Promoting Competition in Markets for Biologics
Joint FDA-FTC Statement Regarding Collaboration to Advance Competition in the Biologic Marketplace
Statement of the FTC Chairman Regarding Announcement that Aveanna Healthcare and Maxim Healthcare Services have Terminated Their Acquisition Agreement
Displaying 281 - 300 of 1504